Immune dysregulation in Down syndrome (DS) is a highly clinically relevant yet underrecognized feature of this common genetic syndrome. Infection is the leading cause of mortality in DS. This infectious risk likely stems from underlying immunodeficiency compounded by their unique intrinsic anatomy. Furthermore, individuals with DS display a broad range of autoinflammatory and autoimmune diseases, spanning dermatologic, neurologic, and metabolic features, which are often difficult to treat with immunomodulators. Through real clinical vignettes of our patients, we will describe how we treat immune dysregulation in DS.
Building similarity graph...
Analyzing shared references across papers
Loading...
Melissa Gans
Matthew Wyke
Kayra Somay
University of Miami
Columbia University Irving Medical Center
Jackson Memorial Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Gans et al. (Sat,) studied this question.
www.synapsesocial.com/papers/69fd7f4fbfa21ec5bbf07cff — DOI: https://doi.org/10.70962/jhi.20250161